|
Volumn 317, Issue 7160, 1998, Pages 713-720
|
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ATENOLOL;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ADULT;
AGED;
ARTICLE;
BLOOD PRESSURE REGULATION;
BRONCHOSPASM;
CLINICAL TRIAL;
DIABETIC ANGIOPATHY;
DIABETIC RETINOPATHY;
DRUG EFFICACY;
EYE PHOTOGRAPHY;
FEMALE;
HUMAN;
HYPOGLYCEMIA;
INTERMITTENT CLAUDICATION;
MAJOR CLINICAL STUDY;
MALE;
MEAN ARTERIAL PRESSURE;
MULTICENTER STUDY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PROTEINURIA;
RANDOMIZED CONTROLLED TRIAL;
WEIGHT GAIN;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
ATENOLOL;
CAPTOPRIL;
CEREBROVASCULAR DISORDERS;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DIABETIC RETINOPATHY;
FOLLOW-UP STUDIES;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPERTENSION;
HYPOGLYCEMIA;
MALE;
MIDDLE AGED;
MYOCARDIAL INFARCTION;
PATIENT COMPLIANCE;
PERIPHERAL VASCULAR DISEASES;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
VISUAL ACUITY;
WEIGHT GAIN;
|
EID: 0032511601
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1879)
|
References (23)
|